Cumberland Pharmaceuticals (CPIX) News Today $4.96 -0.07 (-1.39%) Closing price 04:00 PM EasternExtended Trading$4.94 -0.01 (-0.30%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CPIX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Holdings Lowered by Bridgeway Capital Management LLCBridgeway Capital Management LLC trimmed its stake in shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX - Free Report) by 35.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 184,155 shares of the spMay 14, 2025 | marketbeat.comCUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCHMay 13, 2025 | prnewswire.comCumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025May 10, 2025 | finanznachrichten.deCumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above 200 Day Moving Average - What's Next?Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedMay 10, 2025 | marketbeat.comCumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comCumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...May 7, 2025 | gurufocus.comCumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025May 6, 2025 | prnewswire.comShort Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Declines By 37.4%Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX - Get Free Report) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 141,400 shares, a decline of 37.4% from the March 31st total of 226,000 shares. Currently, 1.8% of the company's shares are sold short. Based on an average daily trading volume, of 1,400,000 shares, the short-interest ratio is currently 0.1 days.May 1, 2025 | marketbeat.comCumberland Pharmaceuticals Shareholders Approve Key ProposalsApril 30, 2025 | investing.comCumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average - Here's WhyCumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell?April 30, 2025 | marketbeat.comCUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATEApril 29, 2025 | prnewswire.comCumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Short Interest Down 22.9% in MarchCumberland Pharmaceuticals Inc. (NASDAQ:CPIX - Get Free Report) saw a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 226,000 shares, a drop of 22.9% from the March 15th total of 293,200 shares. Approximately 2.9% of the company's stock are sold short. Based on an average trading volume of 1,520,000 shares, the short-interest ratio is currently 0.1 days.April 21, 2025 | marketbeat.comCumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above 200-Day Moving Average - Time to Sell?Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?April 20, 2025 | marketbeat.comCumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving Average - Here's WhyCumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above 200 Day Moving Average - Time to Sell?April 12, 2025 | marketbeat.comCumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above 200-Day Moving Average - Time to Sell?Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above Two Hundred Day Moving Average - What's Next?April 4, 2025 | marketbeat.comCumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving Average - What's Next?Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?March 25, 2025 | marketbeat.comFIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific ConferenceMarch 19, 2025 | prnewswire.comWhat $400,000 can buy you in Cumberland County, March 3 to 9March 13, 2025 | nj.comCumberland Pharmaceuticals Full Year 2024 Earnings: US$0.46 loss per share (vs US$0.44 loss in FY 2023)March 13, 2025 | finance.yahoo.comStockNews.com Upgrades Cumberland Pharmaceuticals (NASDAQ:CPIX) to BuyStockNews.com upgraded shares of Cumberland Pharmaceuticals from a "hold" rating to a "buy" rating in a research report on Thursday.March 7, 2025 | marketbeat.comCumberland Pharmaceuticals: Key Insights from Earnings CallMarch 5, 2025 | tipranks.comCumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue GrowthMarch 5, 2025 | finanznachrichten.deCumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | msn.comCumberland Pharmaceuticals (NASDAQ:CPIX) Posts Earnings ResultsCumberland Pharmaceuticals (NASDAQ:CPIX - Get Free Report) announced its quarterly earnings results on Tuesday. The specialty pharmaceutical company reported ($0.03) EPS for the quarter. Cumberland Pharmaceuticals had a negative net margin of 29.54% and a negative return on equity of 9.50%.March 5, 2025 | marketbeat.comCumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Highlights: Revenue Growth and ...March 5, 2025 | gurufocus.comQ4 2024 Cumberland Pharmaceuticals Inc Earnings Call TranscriptMarch 5, 2025 | gurufocus.comCumberland Pharmaceuticals Reports Revenue Growth and Strategic AdvancesMarch 4, 2025 | tipranks.comCumberland Pharmaceuticals Inc (CPIX) Reports Q4 2024 Revenue of $10. ...March 4, 2025 | gurufocus.comCumberland Pharmaceuticals Inc. (CPIX) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comCumberland options imply 26.1% move in share price post-earningsMarch 4, 2025 | markets.businessinsider.comCumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue GrowthMarch 4, 2025 | prnewswire.comShort Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Increases By 161.3%Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX - Get Free Report) saw a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 500,700 shares, an increase of 161.3% from the January 31st total of 191,600 shares. Based on an average daily volume of 3,200,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 6.4% of the shares of the stock are sold short.March 1, 2025 | marketbeat.comCUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTSFebruary 25, 2025 | prnewswire.comCumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200 Day Moving Average - Here's WhyFebruary 22, 2025 | marketbeat.comVIBATIV® RECEIVES MARKETING APPROVAL IN CHINAFebruary 18, 2025 | prnewswire.comCumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Short Interest Down 56.3% in JanuaryCumberland Pharmaceuticals Inc. (NASDAQ:CPIX - Get Free Report) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 191,600 shares, a decrease of 56.3% from the January 15th total of 438,800 shares. Based on an average daily volume of 3,170,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 2.4% of the company's shares are sold short.February 14, 2025 | marketbeat.comCumberland Pharmaceuticals ups common stock offeringFebruary 14, 2025 | msn.comCumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by StockNews.comStockNews.com assumed coverage on Cumberland Pharmaceuticals in a report on Friday. They issued a "hold" rating for the company.February 14, 2025 | marketbeat.comCumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above 200 Day Moving Average - Should You Sell?February 12, 2025 | marketbeat.comCumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on Cumberland Pharmaceuticals in a report on Thursday. They issued a "hold" rating on the stock.February 7, 2025 | marketbeat.comCumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart DiseaseFebruary 4, 2025 | benzinga.comCumberland Vaults on DMD Test ResultsFebruary 4, 2025 | baystreet.caCumberland reports progress in DMD heart disease trialFebruary 4, 2025 | msn.comCumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart DiseaseFebruary 4, 2025 | prnewswire.comCumberland Pharmaceuticals Inc. (CPIX)January 25, 2025 | ca.finance.yahoo.comCumberland County Department of Public Health warns residents of text scams circulatingDecember 20, 2024 | msn.com10 most expensive homes sold in Cumberland County, Dec. 9-15December 20, 2024 | nj.comCumberland woman arrested, stolen vehicle recoveredDecember 20, 2024 | news.yahoo.com3 Penny Stocks to Watch Now, 12/12/24December 12, 2024 | tipranks.comCumberland Stock Soars 90% After FDA Approval for Acetadote Dosing ChangeDecember 11, 2024 | finance.yahoo.com Get Cumberland Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPIX Media Mentions By Week CPIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPIX News Sentiment▼0.810.66▲Average Medical News Sentiment CPIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPIX Articles This Week▼010▲CPIX Articles Average Week Get Cumberland Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OMER News NKTR News ASMB News LLY News JNJ News ABBV News MRK News PFE News BMY News ZTS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPIX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
